Multiple aberrations of chromosome 3p detected in oral premalignant lesions

Cancer Prevention Research

Volumn 1, Issue 6, 2008, Pages 424-429

  Tsui, Ivy F L ^a,b   Rosin, Miriam P ^a   Zhang, Lewei ^b   Ng, Raymond T ^b   Lam, Wan L ^a,b  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 3; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE COURSE; FOLLOW UP; GENE DELETION; GENE DOSAGE; GENETICS; HETEROZYGOSITY LOSS; HUMAN; METABOLISM; MOUTH MUCOSA; MOUTH TUMOR; PATHOLOGY; PRECANCER; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GENE DELETION; GENE DOSAGE; HUMANS; LOSS OF HETEROZYGOSITY; MOUTH MUCOSA; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 61749086926     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-08-0123     Document Type: Article

References (36)

1. Garnis C, Buys TP, Lam WL. Genetic alteration and gene expression modulation during cancer progression. Mol Cancer 2004;3:9.
2. Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 2002;21:6915-35.
3. Mao L, Hong WK, Papadimitrakopoulou VA. Focus on head and neck cancer. Cancer Cell 2004;5: 311-6.
4. Mao L, Lee JS, Fan YH, et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 1996;2:682-5.
5. Partridge M, Pateromichelakis S, Phillips E, Emilion GG, A'Hern RP, Langdon JD. A casecontrol study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization. Cancer Res 2000;60:3893-8.
6. Rosin MP, Cheng X, Poh C, et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 2000;6:357-62.
7. Rosin MP, Lam WL, Poh C, et al. 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Cancer Res 2002;62:6447-50.
8. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56: 2488-92.
9. Baldwin C, Garnis C, Zhang L, Rosin MP, Lam WL. Multiple microalterations detected at high frequency in oral cancer. Cancer Res 2005;65:7561-7.
10. Ishkanian AS, Malloff CA, Watson SK, et al. A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 2004;36: 299-303.
11. Wong KK, deLeeuw RJ, Dosanjh NS, et al. A comprehensive analysis of common copy-number variations in the human genome. Am J Hum Genet 2007;80:91-104.
12. Coe BP, Lockwood WW, Girard L, et al. Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer. Br J Cancer 2006; 94:1927-35.
13. Chari R, Lockwood WW, LamWL. Computational methods for the analysis of array comparative genomic hybridization. Cancer Inform 2006;2:48-58.
14. Khojasteh M, Lam WL, Ward RK, MacAulay C. A stepwise framework for the normalization of array CGH data. BMC Bioinformatics 2005;6:274.
15. Chi B, DeLeeuw RJ, Coe BP, MacAulay C, Lam WL. SeeGH - a software tool for visualization of whole genome array comparative genomic hybridization data. BMC Bioinformatics 2004;5:13.
16. Jong K, Marchiori E, Meijer G, Vaart AV, Ylstra B. Breakpoint identification and smoothing of array comparative genomic hybridization data. Bioinformatics 2004;20:3636-7.
17. Olshen AB, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004;5:557-72.
18. Shah SP, Xuan X, DeLeeuw RJ, et al. Integrating copy number polymorphisms into array CGH analysis using a robust HMM. Bioinformatics 2006;22:e431-9.
19. Lee JI, Soria JC, Hassan K, et al. Loss of Fhit expression is a predictor of poor outcome in tongue cancer. Cancer Res 2001;61:837-41.
20. Smeets SJ, Braakhuis BJ, Abbas S, et al. Genomewide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene 2006;25:2558-64.
21. Snijders AM, Schmidt BL, Fridlyand J, et al. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 2005;24:4232-42.
22. Chakraborty SB, Dasgupta S, Roy A, et al. Differential deletions in 3p are associated with the development of head and neck squamous cell carcinoma in Indian patients. Cancer Genet Cytogenet 2003;146:130-8.
23. Garnis C, Baldwin C, Zhang L, Rosin MP, Lam WL. Use of complete coverage array comparative genomic hybridization to define copy number alterations on chromosome 3p in oral squamous cell carcinomas. Cancer Res 2003;63:8582-5.
24. Kayahara H, Yamagata H, Tanioka H, Miki T, Hamakawa H. Frequent loss of heterozygosity at 3p25-p26 is associated with invasive oral squamous cell carcinoma. J Hum Genet 2001;46:335-41.
25. Noutomi Y, Oga A, Uchida K, et al. Comparative genomic hybridization reveals genetic progression of oral squamous cell carcinoma from dysplasia via two different tumourigenic pathways. J Pathol 2006;210:67-74.
26. Riddick AC, Shukla CJ, Pennington CJ, et al. Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues. Br J Cancer 2005;92:2171-80.
27. Haider AS, Peters SB, Kaporis H, et al. Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. J InvestDermatol 2006;126:869-81.
28. Ishiguro H, Tsunoda T, Tanaka T, Fujii Y, Nakamura Y, Furukawa Y. Identification of AXUD1, a novel human gene induced by AXIN1 and its reduced expression in human carcinomas of the lung, liver, colon and kidney. Oncogene 2001;20:5062-6.
29. Kashuba VI, Li J, Wang F, et al. RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies. Proc Natl Acad Sci U S A 2004;101:4906-11.
30. Kujan O, Oliver R, Roz L, et al. Fragile histidine triad expression in oral squamous cell carcinoma and precursor lesions. Clin Cancer Res 2006;12:6723-9.
31. Michalik L, Desvergne B, Wahli W. Peroxisomeproliferator-activated receptors and cancers: complex stories. Nat Rev Cancer 2004;4:61-70.
32. Sengupta S, Chakrabarti S, Roy A, Panda CK, Roychoudhury S. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. Cancer 2007;109:703-12.
33. Winn RA, Van Scoyk M, Hammond M, et al. Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferatoractivated receptor γ. J Biol Chem 2006;281: 26943-50.
34. You KT, Li LS, Kim NG, et al. Selective translational repression of truncated proteins from frameshift mutation-derived mRNAs in tumors. PLoS Biol 2007;5:e109.
35. Rush LJ, Raval A, Funchain P, et al. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Res 2004;64: 2424-33.
36. Bierie B, Moses HL. Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 2006;6:506-20.